Literature DB >> 15658869

Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.

Ana B S Maya1, Concepción Pérez-Melero, Carmen Mateo, Dulce Alonso, José Luis Fernández, Consuelo Gajate, Faustino Mollinedo, Rafael Peláez, Esther Caballero, Manuel Medarde.   

Abstract

By synthesis and biological studies of new naphthalene analogues of combretastatins, we have found that the naphthalene is a good surrogate for the isovanillin moiety (3-hydroxy-4-methoxyphenyl) of combretastatin A-4, always generating highly cytotoxic analogues when combined with the 3,4,5-trimethoxyphenyl or related systems. On the other hand, when the naphthalene replaces the 3,4,5-trimethoxyphenyl moiety, the cytotoxic activity is largely decreased. The most cytotoxic naphthalene analogues of combretastatins, which also produce inhibition of tubulin polymerization, exerted their antimitotic effects through microtubule network disruption and subsequent G(2)/M arrest of the cell cycle in human cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15658869     DOI: 10.1021/jm0310737

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Highly potent triazole-based tubulin polymerization inhibitors.

Authors:  Qiang Zhang; Youyi Peng; Xin I Wang; Susan M Keenan; Sonia Arora; William J Welsh
Journal:  J Med Chem       Date:  2007-01-24       Impact factor: 7.446

2.  Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.

Authors:  Narsimha Reddy Penthala; Hongliang Zong; Amit Ketkar; Nikhil Reddy Madadi; Venumadav Janganati; Robert L Eoff; Monica L Guzman; Peter A Crooks
Journal:  Eur J Med Chem       Date:  2014-12-29       Impact factor: 6.514

3.  Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.

Authors:  Bernard L Flynn; Gurmit S Gill; Damian W Grobelny; Jason H Chaplin; Dharam Paul; Annabell F Leske; Tina C Lavranos; David K Chalmers; Susan A Charman; Edmund Kostewicz; David M Shackleford; Julia Morizzi; Ernest Hamel; M Katherine Jung; Gabriel Kremmidiotis
Journal:  J Med Chem       Date:  2011-08-05       Impact factor: 7.446

4.  Design, Synthesis and Biochemical Evaluation of Novel Selective Estrogen Receptor Ligand Conjugates Incorporating an Endoxifen-Combretastatin Hybrid Scaffold.

Authors:  Niall O Keely; Miriam Carr; Bassem Yassin; Gloria Ana; David G Lloyd; Daniela Zisterer; Mary J Meegan
Journal:  Biomedicines       Date:  2016-07-20

5.  3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking.

Authors:  Yinghua Jin; Ping Qi; Zhiwei Wang; Qirong Shen; Jian Wang; Weige Zhang; Hongrui Song
Journal:  Molecules       Date:  2011-08-08       Impact factor: 4.411

6.  The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.

Authors:  Myriam González; Younes Ellahioui; Raquel Álvarez; Laura Gallego-Yerga; Esther Caballero; Alba Vicente-Blázquez; Laura Ramudo; Miguel Marín; Cristina Sanz; Manuel Medarde; Rafael Pelaéz
Journal:  Molecules       Date:  2019-11-26       Impact factor: 4.411

7.  Novel 3-(3, 5-difluoro-4-hydroxyphenyl)-1-(naphthalen-2-yl) prop-2-en-1-one as a potent inhibitor of MAP-kinase in HeLa cell lines and anti-angiogenic activity is mediated by HIF-1α in EAC animal model.

Authors:  Dileep Kumar M Guruswamy; Kyathegowdana Doddi Srivinavasa Balaji; Kattepura Krishnappa Dharmappa; Shankar Jayarama
Journal:  Oncotarget       Date:  2020-12-15

8.  Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression.

Authors:  Igor Nasibullin; Ivan Smirnov; Peni Ahmadi; Kenward Vong; Almira Kurbangalieva; Katsunori Tanaka
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

9.  Design, synthesis and cytotoxic evaluation of o-carboxamido stilbene analogues.

Authors:  Mohamad Nurul Azmi; Mohd Fadzli Md Din; Chin Hui Kee; Munirah Suhaimi; Ang Kheng Ping; Kartini Ahmad; Mohd Azlan Nafiah; Noel F Thomas; Khalit Mohamad; Leong Kok Hoong; Khalijah Awang
Journal:  Int J Mol Sci       Date:  2013-11-27       Impact factor: 5.923

10.  Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.

Authors:  Guangcheng Wang; Wenjing Liu; Meiyan Fan; Min He; Yongjun Li; Zhiyun Peng
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.